Company / Operating Income per Share
BioMarin Pharmaceutical Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$2.13
FY2025
5-year range
-$0.45 / $2.54
FY2021-FY2025
Trend
-16.1%
vs FY2024
Sector context
#29 of 201
Health Care
What the data says
BioMarin Pharmaceutical's operating income per share of $2.13 is higher than 86% of companies in the Health Care sector (FY2025). Operating Income per Share has fluctuated over the past 10 years, ranging from $-4.65 in FY2016 to $2.54 in FY2024.
Based on SEC 10-K filings.
2.13 in FY2025 with a 3-year CAGR of +35.1%. Top quartile in the Health Care sector.
Improved from $0.99 to $2.13 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- +35.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
+107.5% above sector average
Key checks
Key Insights
- In FY2025, operating income per share decreased 16.1% year-over-year.
- Ranks #29 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2024.
- Lowest operating income per share in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.13 | -16.1% |
| FY2024 | $2.54 | +157.7% |
| FY2023 | $0.99 | +14.0% |
| FY2022 | $0.86 | +290.8% |
| FY2021 | -$0.45 | -89.6% |
| FY2020 | -$0.24 | +57.2% |
| FY2019 | -$0.56 | +19.4% |
| FY2018 | -$0.69 | -728.9% |
| FY2017 | -$0.08 | +98.2% |
| FY2016 | -$4.65 | -579.0% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026